NCT06473623 Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder
| NCT ID | NCT06473623 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Neuropix |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-12-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum Disorder
Eligibility Criteria
Inclusion Criteria: * Written informed consent * Age: between 7 and 26 years * Participants and parent/ guardian must have proficiency in English * Diagnosis of ASD as defined by ADOS-2 or DSM-5 criteria Exclusion Criteria: * Severe psychiatric disorders (e.g. bipolar, major depressive disorder) * Severe neurological disorders (e.g. stroke, epilepsy) * Bradyarrhythmia * History of head trauma (surgery or tumor) * Active medical implants (cochlear, VNS or pacemakers) * Cerebral shunts * Auricular skin disease that compromises placement of electrodes * Pregnancy
Contact & Investigator
Daniel Ko, PhD
PRINCIPAL INVESTIGATOR
Neuropix
Frequently Asked Questions
Who can join the NCT06473623 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 26 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06473623 currently recruiting?
Yes, NCT06473623 is actively recruiting participants. Contact the research team at danielko@neuro-pix.com for enrollment information.
Where is the NCT06473623 trial being conducted?
This trial is being conducted at Tai Po, Hong Kong.
Who is sponsoring the NCT06473623 clinical trial?
NCT06473623 is sponsored by Neuropix. The principal investigator is Daniel Ko, PhD at Neuropix. The trial plans to enroll 20 participants.